Vitiligo
224
20
35
92
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
22 trials with published results (10%)
Research Maturity
92 completed trials (41% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
6.7%
15 terminated out of 224 trials
86.0%
-0.5% vs benchmark
14%
31 trials in Phase 3/4
24%
22 of 92 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 92 completed trials
Clinical Trials (224)
Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
The Gut and Skin Microbiome in Vitiligo Disease Progression
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo
The Value of Methotrexate in NCES for Stable Vitiligo
Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo
A Phase 2 Study of D-2570 in Subjects With Non-Segmental Vitiligo
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo
Efficacy and Safety of Ruxolitinib Cream in Chinese Children Aged 2-11 Years With Non-segmental Vitiligo
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients.
Oral Mini Pulse Dexamethasone in Pediatric Vitiligo
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
Evaluation of AMG 714 for Vitiligo
Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo
Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo
Vitiligo Registry for Adults and Children in the UK
Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO
Atorvastatin in Active Vitiligo